InspireMD (NSPR) Cash from Investing Activities Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -40.94% |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | -138.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -138.78% |
| Sep 30, 2025 | 39.96% |
| Jun 30, 2025 | 41.81% |
| Mar 31, 2025 | 204.32% |
| Dec 31, 2024 | 64.81% |
| Sep 30, 2024 | 37.43% |
| Jun 30, 2024 | 298.28% |
| Mar 31, 2024 | 487.43% |
| Dec 31, 2023 | 29.79% |
| Sep 30, 2023 | 409.58% |
| Jun 30, 2023 | -853.71% |
| Mar 31, 2023 | 1,040.89% |
| Dec 31, 2022 | 287.80% |
| Sep 30, 2022 | 215.14% |
| Jun 30, 2022 | 160.52% |
| Mar 31, 2022 | 14.77% |
| Jun 30, 2021 | -45.86% |
| Mar 31, 2021 | -25.99% |
| Dec 31, 2020 | -42.42% |
| Sep 30, 2020 | 17.42% |
| Jun 30, 2020 | 7.37% |
| Mar 31, 2020 | 73.21% |
| Dec 31, 2019 | -84.42% |
| Sep 30, 2019 | -47.99% |
| Jun 30, 2019 | -99.58% |
| Mar 31, 2019 | -46.85% |
| Jun 30, 2018 | -73.49% |
| Mar 31, 2018 | -2.94% |
| Mar 31, 2017 | -66.17% |
| Sep 30, 2016 | 35.88% |
| Jun 30, 2016 | 28.25% |
| Mar 31, 2016 | 47.61% |
| Dec 31, 2015 | 38.26% |
| Mar 31, 2015 | 38.80% |
| Mar 31, 2014 | 30.66% |
| Sep 30, 2013 | -12.62% |